This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Osteopenic

Authoring team

Osteopenia is defined as a reduction in bone density.

The term is often used radiologically when it describes a qualitative appearance of bone on a radiograph.

Increasingly however the term refers to a quantitative loss of bone mineral density usually measured either at the hip or spine with dual energy X ray aborptiometry.

Osteopaenia is defined when bone density at the spine or hip between 1.0 and 2.5 standard deviations below the average for healthy young adults (T-score between -1 and -2.5).

Osteoporosis is defined if the T-score is more than 2.5 standard deviations below the average.

Normal bone mineral density is : T-score of -1 standard deviations or above

Management:

  • lifestyle advice
    • balanced diet including adequate calcium and vitamin D
    • regular weight-bearing exercise eg. walking, dancing, skipping, gym
    • stop smoking
    • reduce alcohol intake

  • zoledronic acid may be considered to reduce risk of clinical fractures in women over 65 years of age who have osteopenia at hip or femoral neck on DXA (2)

  • patients with osteopenia (t score -1 to -2.5) should be re- scanned in 3 years

Reference:

  • Wirral University Hospital NHS Foundation Trust. Wirral guidelines for the management of osteoporosis.
  • SIGN (June 2020). Management of osteoporosis and the prevention of fragility fractures

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.